Bjørg Hjerkinn

Learn More
BACKGROUND Naltrexone has considerable potential in helping to prevent relapse in heroin dependency. A longer-lasting formulation for naltrexone treatment is desirable to further reduce non-adherence and relapse during treatment of opiate dependence. AIMS To evaluate the safety and effectiveness of a 6-month naltrexone implant in reducing opioid use after(More)
BACKGROUND Substance abuse during pregnancy may harm the foetus and can cause neonatal abstinence syndrome. Exposure to alcohol and other substances can influence the child for the rest of its life. A special child welfare clinic was set up in 1994 in Kristiansand, Norway, targeting pregnant women with substance abuse problems in the county of Vest-Agder.(More)
acological efficacy in blocking the actions of heroin, 1 its clinical usefulness has proved limited. 2 Many people who are opiate-dependent are reluctant or refuse to take naltrexone; 3,4 many others begin but do not continue treatment. 5–7 Sustained-release opioid antagonist treatment removes the requirement for patients to take daily doses of the(More)
BACKGROUND Exposure to alcohol and illicit substances during pregnancy can have an impact on the child for the rest of his/her life. A Special Child Welfare Clinic (SCWC) in Norway provides care for pregnant women with substance abuse problems. Treatment and support are provided without replacement therapy. METHODS We performed a neuropsychological(More)
  • 1